BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2663330)

  • 21. Role of early adjuvant hormonal therapy after radical prostatectomy for prostate cancer.
    Zincke H; Lau W; Bergstralh E; Blute ML
    J Urol; 2001 Dec; 166(6):2208-15. PubMed ID: 11696737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term results of adjuvant hormonal therapy plus radiotherapy following radical prostatectomy for patients with pT3N0 or pT3N1 prostate cancer.
    Miyake H; Sakai I; Harada K; Hara I; Eto H
    Int J Urol; 2004 Jun; 11(6):397-401. PubMed ID: 15157209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of primary hormonal therapy for patients with localized and locally advanced prostate cancer: a retrospective multicenter study.
    Ueno S; Namiki M; Fukagai T; Ehara H; Usami M; Akaza H
    Int J Urol; 2006 Dec; 13(12):1494-500. PubMed ID: 17118024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population based study of hormonal therapy and survival in men with metastatic prostate cancer.
    Lu-Yao G; Moore DF; Oleynick JU; DiPaola RS; Yao SL
    J Urol; 2007 Feb; 177(2):535-9. PubMed ID: 17222628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A retrospective review of combination chemohormonal therapy as initial treatment for locally advanced or metastatic adenocarcinoma of the prostate.
    Amato RJ; Teh BS; Henary H; Khan M; Saxena S
    Urol Oncol; 2009; 27(2):165-9. PubMed ID: 18367115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Epidemiology of prostate cancer from three centers and analysis of the first-line hormonal therapy for the advanced disease].
    Ma CG; Ye DW; Li CL; Zhou FJ; Yao XD; Zhang SL; Dai B; Zhang HL; Zhu Y; Shen YJ
    Zhonghua Wai Ke Za Zhi; 2008 Jun; 46(12):921-5. PubMed ID: 19035151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advanced prostate cancer.
    Waxman SW; Crawford ED
    Surg Technol Int; 1995; IV():266-70. PubMed ID: 21400446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostate cancer: current and evolving strategies.
    Cersosimo RJ; Carr D
    Am J Health Syst Pharm; 1996 Feb; 53(4):381-96; quiz 446-8. PubMed ID: 8673658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostate cancer. Primary hormonal treatment.
    Denis L
    Cancer; 1993 Feb; 71(3 Suppl):1050-8. PubMed ID: 8428327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advanced prostate cancer. Endocrine therapies and palliative measures.
    Taub M; Begas A; Love N
    Postgrad Med; 1996 Sep; 100(3):139-40, 143-6, 152 passim. PubMed ID: 8795651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Future developments of nonhormonal systemic therapy for prostatic carcinoma.
    Warner JA; Heston WD
    Urol Clin North Am; 1991 Feb; 18(1):25-33. PubMed ID: 1992572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostate cancer: a model of cancer in the elderly.
    Balducci L; Khansur T; Smith T; Hardy C
    Arch Gerontol Geriatr; 1989 Mar; 8(2):165-87. PubMed ID: 2660761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapy of prostatic cancer and histopathologic follow-up.
    Dhom G; Degro S
    Prostate; 1982; 3(6):531-42. PubMed ID: 7155986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current concepts in the treatment of prostate cancer.
    Melamed AJ
    Drug Intell Clin Pharm; 1987 Mar; 21(3):247-54. PubMed ID: 3552544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Homocysteine-reducing B vitamins and ischemic heart disease: a separate-sample Mendelian randomization analysis.
    Zhao JV; Schooling CM
    Eur J Clin Nutr; 2017 Feb; 71(2):267-273. PubMed ID: 27901035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostate cancer: a comprehensive review.
    Pentyala SN; Lee J; Hsieh K; Waltzer WC; Trocchia A; Musacchia L; Rebecchi MJ; Khan SA
    Med Oncol; 2000 May; 17(2):85-105. PubMed ID: 10871814
    [No Abstract]   [Full Text] [Related]  

  • 37. Controversies in the management of advanced prostate cancer.
    Tyrrell CJ
    Br J Cancer; 1999 Jan; 79(1):146-55. PubMed ID: 10408706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leuprorelin. A review of its pharmacology and therapeutic use in prostatic disorders.
    Chrisp P; Sorkin EM
    Drugs Aging; 1991; 1(6):487-509. PubMed ID: 1794035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of prostate cancer.
    Korman LB
    Clin Pharm; 1989 Jun; 8(6):412-24. PubMed ID: 2663330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of advanced prostatic cancer.
    Sogani PC; Fair WR
    Urol Clin North Am; 1987 May; 14(2):353-71. PubMed ID: 2953100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.